To determine whether all tumor areas are accessible to intravenously administered vectors, we injected scAAV2.CMV.eGFP vectors into tumor-bearing TGFα/c-myc HCC mice and stained tumor sections for eGFP using an anti-eGFP antibody. This evidence concerns the gene TGFA and hepatocellular carcinoma.